All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Introducing
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene and Roche, and supported through educational grants from Bristol Myers Squibb, Ipsen Biopharmaceuticals, Pfizer, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC View funders.
The Lymphoma Hub is published by Scientific Education Support Ltd (SES) and is committed to protecting your personal information and being transparent about what information we hold about you. We promise to respect any personal data you share with us and keep it safe.
This Privacy Policy sets out the data processing practices of the Lymphoma Hub; all data that we hold will be used, and held, in accordance with the requirements of the General Data Protection Regulation (GDPR) and the Data Protection Act 2018.
With open access and science-driven global initiatives, SES provides unbiased disease education through multichannel communications and educational websites such as the Lymphoma Hub. Our purpose is to provide credible education in lymphoma & CLL where there is an unmet medical need. We do this by providing the latest medical information, live congress coverage, trial updates, drug approvals, case studies as well as expert opinions.
If you have queries about this policy, please contact the Data Protection Officer, Lymphoma Hub, SES Limited, 12 Princes Gardens, London, W3 0LJ, call us on 01372 472140 or email secretariat@scientificeducationsupport.com
We will obtain personal information about you when you sign up for the Lymphoma Hub newsletter, participate in a website survey, or create a My Lymphoma Hub account.
This information is collected to allow us to provide you with the most relevant content & to personalise your experience while using the Lymphoma Hub. This includes things like:
We collect some infomation about you when you supply this directly by filling out registration or newsletter sign-up forms. This will include a name, email address, occupation & country of practice.
We also collect information about your preferences and website activity when you add bookmarks or areas of interest to your My Lymphoma Hub dashboard. This will include article names or categories of content you have stored within your profile.
Depending on your personal cookie settings, Lymphoma Hub can also collect information on how you use the website. Using Google Analytics, we capture geographic location, the date and time of visits, pages viewed, and time spent on each page, including the website visited before and after our own site. We use cookies to track this information on your computer. Please read our Cookie Policy for more information.
Scientific Education Support uses captured data to create anonymised quarterly reports, for internal teams, external sponsors, and partners to support open-access funding for our website.
We collect this anonymised data to share key performance metrics across our websites, including popular content and categories, our geographic reach including the languages used to read our content.
For registered users, we also collect anonymised information based on personal My Lymphoma Hub account activity. This may include statistics for selected areas of interest, popular bookmarked content, or aggregated statistics by profession or country of practice.
We do not share any identifying personal information with third parties, supporters, or affiliated organiations. Wherever possible we use aggregated, anonymous data that does not identify individual users on our website.
We will never use personal data you have provided for marketing purposes unless consent is given by you via opt-in in advance, nor will your personal information be passed to any third parties.
We will keep your personal data as long as is required to send you the information you have requested.
All our newsletter emails have a clear 'unsubscribe' link which will remove you from future email communications and delete any personal information held in our database.
If you have previously registered and would like to close your user account and delete any personal information stored, please contact our team using the email address found on the 'Account Settings' page. We will close the account and remove personal information held within 1 month of the initial request.
Under the GDPR you have the right to:
If you wish to find out more about these rights, or obtain a copy of the information we hold about you, please contact us on 01372 472140 or secretariat@scientificeducationsupport.com
If you are unhappy with any aspect of our handling of your data, you can make a complaint to the Information Commissioner’s Office - https://ico.org.uk/concerns/
Our website may contain links to other websites that are outside our control and are not covered by this Privacy Policy. If you access other sites using the links provided, the operators of these sites may collect information from you that will be used by them in accordance with their Privacy Policy, which may differ from ours.
This Privacy Policy is regularly reviewed and will be updated when necessary. If we make any significant changes to the policy, then we will communicate these to you.
Last updated: October 2024